Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...
Patent
1990-03-03
1993-12-28
Stoll, Robert L.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
5303913, A61K 4300, A61K 4902
Patent
active
052737381
ABSTRACT:
A method of selectively delivering radiation homogeneously to lymphoid and marrow tissues in vivo including the step of administering an effective dose of a radiolabeled immunological binding partner of a T-200 antigen to a patient is disclosed. Also disclosed are immunological binding partners and compositions based thereon for carrying out the method.
REFERENCES:
patent: 4582797 (1986-04-01), Trowbridge
patent: 4626507 (1986-12-01), Trowbridge et al.
patent: 4911690 (1990-03-01), Mulshine et al.
patent: 5002869 (1991-03-01), Schlossman et al.
patent: 5028424 (1991-07-01), Evans
patent: 5091178 (1992-02-01), Hellstrom et al.
Nourigat, C., et al., "Treatment of Lymphoma With Radiolabeled Antibody: Elimination of Tumor Cells Lacking Target Antigen," Journal of the National Cancer Institute 82(1):47-50 (Jan. 1990).
Thomas, M. L., The leukocyte common antigen family, Ann. Rev. Immunol. 7:339-369, 1989.
Thomas, M. L. et al., Differential expression of the leucocyte-common antigen family, Immunology Today 9(10):320-326, 1988.
Clark, E. A. et al., Leukocyte cell surface enzymology: CD45 (LCA, T200) is a protein tyrosine phosphatase, Immunology Today 10(7):225-228, 1989.
Tonks, N. K. et al., Demonstration that the leukocyte common antigen CD45 is a protein tyrosine phosphatase, Biochemistry 27(24):8701-8706, 1988.
Shah, V. O. et al., Flow cytometric analysis of human bone marrow. IV. Differential quantitative expression of T-200 common leukocyte antigen during normal hemopoiesis, The Journal of Immunology 140(6):1861-1867, 1988.
Ralph, S. J. et al., Structural variants of human T200 glycoprotein (leukocyte-common antigen), The EMBO Journal 6(5):1251-1257, 1987.
Omary, M. B. et al., Human homologue of murine T200 glycoprotein, J. Exp. Med. 152:842-852, 1980.
Ledbetter, J. A. et al., CD45 regulates signal transduction and lymphocyte activation by specific association with receptor molecules on T or B cells. Proc. Natl. Acad., Sci. USA 85:8628-8632, 1988.
Charbonneau, H. et al., The leukocyte common antigen (CD45): A putative receptor-linked protein tyrosine phosphatase, Proc. Natl. Acad. Sci. USA 85:7182-7186, 1988.
McMichael, A. J. et al., Eds. Chapter 15: Non-lineage, LFA-1 family, and leucocyte common antigens, in Leukocyte Typing III: White Cell Differentiation Antigens, Oxford University Press, 1987.
Starling, G. C. et al., Inhibition of natural killer-cell mediated cytolysis with monoclonal antibodies to restricted and non-restricted epitopes of the leucocyte common antigen, Immunology 61:351-356, 1987.
Tighe, H. et al., Blocking of cytotoxic T cell function by monoclonal antibodies against the CD45 antigen (T200/leukocyte-common antigen), Transplantation 44(6):818-823, 1987.
Andres, T. L. et al., Immunologic markers in the differential diagnosis of small round cell tumors from lymphocytic lymphoma and leukemia, Am. J. Clin. Path. 79(5):546-552, 1983.
Bindon, C. I. et al., Therapeutic potential of monoclonal antibodies to the leukocyte-common antigen, Transplantation 40(5):538-544, 1985.
Fabre, J. W. et al., Immunosuppressive properties of rabbit antibodies against a major glycoprotein restricted to rat leukocyte membranes, Transplantation 30(3):167-173, 1980.
Harp, J. A. et al., Modulation of in vitro immune responses by monoclonal antibody to T200 antigen, Immunology 81:71-80, 1983.
Ledbetter, J. A. et al., Antibodies to common leukocyte antigen p220 influence human T cell proliferation by modifying IL 2 receptor expression, The Journal of Immunology 135(3):1819-1825, 1985.
Martorell, J. et al., A second signal for T cell mitogenesis provided by monoclonal antibodies CD4
This invention was made with government support under National Institutes of Health grant Nos. CA44991, CA26386, and CA29548 awarded by the National Institutes of Health. The government has certain rights in the invention.
Anasetti Claudio
Appelbaum Fred R.
Bernstein Irwin D.
Hansen John A.
Martin Paul J.
Chapman Lara E.
Fred Hutchinson Cancer Research Center
Stoll Robert L.
LandOfFree
Radiation delivery to lymphoid and marrow tissues does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radiation delivery to lymphoid and marrow tissues, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radiation delivery to lymphoid and marrow tissues will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1541182